2020 annual financial data

Sutro Biopharma, Inc. 2020 Financial results

Sutro Biopharma, Inc. 2020 financial results with verified reported values.

Direct answer

Revenue was 42,722,000 USD.

Operating income was -71,057,000 USD and net income was -32,128,000 USD.
Operating cash flow was -67,802,000 USD.

Get free Sutro Biopharma, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
42,722,000 USD
Operating income
-71,057,000 USD
Net income
-32,128,000 USD
Operating cash flow
-67,802,000 USD